openPR Logo
Press release

Autism Disorder and Treatment Market Pipeline Review and Industry Trend Analysis By Pfizer Inc., Eli Lilly and Company, Allergan, Merck & CO Inc., Teva Pharmaceutical Industries, etc

02-24-2020 02:39 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Autism Disorder and Treatment Market

Autism Disorder and Treatment Market

The global autism disorder and treatment market is expected to exhibit a CAGR of 4.37% over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global autism disorder and treatment market was valued at USD 5,143.6 million in 2016 and is likely to exhibit rapid growth over the forecast period due to the rising awareness about autism spectrum disorders (ASD) and the growing efforts being put into drug development for treating autism.

Latest Free Sample PDF Available @https://www.marketresearchfuture.com/sample_request/1605

Autism spectrum disorders are a range of neurobehavioral disorders that affect the ability of the patients to communicate with others. The diseases may also manifest in the form of a lack of social skills, difficulty in understanding nonverbal communication as well as speech, and other symptoms. The etiology and development of autism is not well understood, but the symptoms present themselves most strongly around the age of two to three years. The treatment of autism spectrum disorders is also not well understood, with several options being present in the global market but none presenting a foolproof solution, due to the simple fact that ASD presents differently in each child, with the unique strengths and weaknesses of each individual autism patient needing to be taken into account before a decision is made regarding the long-term treatment plan for the disease.

Growing awareness about autism spectrum disorders is likely to be a major driver for the global autism disorder and treatment market over the forecast period, as the overall awareness about the prevalence of autism spectrum disorders and their treatment is lacking, especially in emerging economies. Growing efforts into autism research are likely to remain a key driver for the global autism disorder and treatment market over the forecast period. Rising efforts by parents to seek out individually oriented treatments for autistic children are likely to be a major driver for the global autism disorder and treatment market.

Segmentation:

The global autism disorder and treatment market is segmented by type, treatment type, drugs, and region.

By type, the global autism disorder and treatment market is segmented into Asperger syndrome, pervasive developmental disorder, and others. Pervasive developmental disorder holds the highest share in the global autism disorder and treatment market and is likely to grow at a CAGR of 4.73% over the forecast period.

By treatment type, the autism disorder and treatment market is segmented into ABA (applied behavioral analysis), hyperbaric oxygen therapy, chelation therapy, oxytocin therapy, and others. The applied behavior analysis segment holds a dominant share of close to 40% in the global autism disorder and treatment market, followed by chelation with 19%. The ABA segment is expected to grow at a rapid 4.82% CAGR over the forecast period, further increasing its dominance in the global autism disorder and treatment market.

By drug, the market is segmented into SSRIs, anti-convulsant, stimulants, and anti-psychotic medication. The anti-psychotic medication segment accounted for the largest share in the global autism disorder an treatment market in 2016 and is expected to exhibit a robust 3.95% CAGR over the forecast period. Anti-psychotics are further segmented into Abilify (aripiprazole) and Risperidone.

Regional Analysis:

The global autism disorder and treatment market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas segment holds the dominant share in the global autism disorder and treatment market due to the growing prevalence of autism in the region and the high awareness among parents about the disease. The increasing availability of advanced autism disorder medication and treatment in the U.S. and Canada is likely to be the major driver for the autism disorder and treatment market in the Americas over the forecast period.

Competitive Analysis:

Leading players in the global autism disorder and treatment market include Pfizer Inc., Allergan, Teva Pharmaceutical Industries Ltd., Novartis AG, Bristol-Myers Squibb, Coronis Partners Ltd., Heptares Therapeutics Limited, Saniona AB, Intra-Cellular Therapies Inc., Curemark LLC, Otsuka Holdings Co. Ltd., Johnson & Johnson Services Inc., Consern Pharma Private Limited, Merck & Co. Inc., and Eli Lilly and Company.

Read More @ https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605

Industry Updates:

Delta Township, Michigan will celebrate "Delta for Autism Awareness Day" on March 18. Such local-level efforts to raise awareness could be crucial for the global autism disorder and treatment market over the forecast period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autism Disorder and Treatment Market Pipeline Review and Industry Trend Analysis By Pfizer Inc., Eli Lilly and Company, Allergan, Merck & CO Inc., Teva Pharmaceutical Industries, etc here

News-ID: 1943013 • Views: 547

More Releases from Market Research Future

Neurorehabilitation Devices Market Analysis By Top Companies : Hocoma AG, Ekso B …
Neurorehabilitation Devices Market Analysis The neurorehabilitation devices market is anticipated to touch USD 2.25 billion between 2013-2022, states the latest Market Research Future (MRFR) report. Neurorehabilitation devices are therapeutic devices that are utilized in rehabilitation programs. It deals with daunting challenges to learn to live with different neurological conditions including amyotrophic lateral sclerosis, peripheral nervous disorders, spinal cord injuries, brain tremor, multiple sclerosis, Parkinson's disease, epilepsy, ADHD, and Alzheimer's disease. Besides,
Microfluidics Devices Market Technology Improvements, Industry Share, Global Tre …
Detail Analysis of Global Microfluidics Devices Market with respect to region specific market growth and competitive analysis on the basis of major players present in the market. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes America, Europe, Asia Pacific and Middle East and Africa. Forecast till 2023 The Microfluidics Devices Market is continually growing mainly due to the
Clear Aligners Market Size 2020, Share, Industry Growth, Global Analysis, Resear …
Global Clear Aligners Market Research Report: Information by Product Type (Hard, Medium and Soft), Age (Adult and Teenager), Distribution Channel (Direct Sales and Laboratories) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 Clear Aligners Market Overview Global Clear Aligners Market size is expected to register 20.80% CAGR and is anticipated to reach USD 7019.96 Million by 2025, according to the latest market research report from
Endodontic Devices Market Is Set To Witness A CAGR Of 5.34% By 2023
Global Endodontic Devices Market Research Report: Information by Product (Consumables (Endodontic Burs) & Instruments), End User (Dental Clinics, Dental Hospitals, Laboratories, and Dental Academic & Research Institutes) & Region--Global Forecast till 2023 Endodontic Devices Market Scenario Endodontic devices comprise an extensive line of instruments & accessories used in the treatments of dental diseases & disorders, ranging from routine root canals to complex microsurgeries. These devices are designed to deliver outstanding patient care

All 5 Releases


More Releases for Autism

Autism-Pipeline Review H1 2018
ReportsWeb.com has announced the addition of the “Global Autism Market Size Status and Forecast 2018”, The report classifies the global Autism Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Pharmaceutical and Healthcare disease pipeline guide Autism-Pipeline Review, H1 2018, provides an overview of the Autism (Central Nervous System) pipeline landscape.Autism, also known as complex
Autism-Pipeline Review H1 2018
Pharmaceutical and Healthcare disease pipeline guide Autism-Pipeline Review, H1 2018, provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include child's sex, family history, fragile X syndrome, Tourette syndrome and epilepsy. Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics, and sedatives. Report Highlights Publisher's Pharmaceutical
The U.S. Autism Treatment Market
Bharat Book Bureau Provides the Trending Market Research Report; on “The U.S. Autism Treatment Market”. The incidence of Autism among American children has soared from 1 in 150 in 2000 to 1 in 45 today, and 2.1 million children and adults now live with autism. Yet, few therapies exist to treat this disease - just a few medications and ABA (applied behavioral analysis) programs. This is a fragmented $1.8 billion market
Autism-Pipeline Review H2 2017
Summary:                                      ReportsWeb.com published “Autism-Pipeline Review H2 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Autism-Pipeline Review H2 2017 provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism also known as complex developmental disability is a neurodevelopment disorder characterized by social interaction verbal
Autism Podcast released for Autism Sunday‏
AUTISM PODCAST RELEASED by Midnight in Chicago FOR AUTISM SUNDAY on February 8, 2009 Peterborough, ON: Thomas D. Taylor and Peterborough based MIDNIGHT IN CHICAGO have released their most recent free audio podcast on Autism entitled “Why Is There Autism: A Christian Perspective” to coincide with Autism Sunday on February 8. “As a Christian, it’s important for me to help others better understand what the Bible says about differences such as Autism,”
POWERED UP AGAINST AUTISM
Celebrities Come Out For the Cause BEVERLY HILLS, CA., NOVEMBER 17, 2007: Nearly one hundred celebrities powered up and showed their support over two days for the fight against autism by signing a special edition BugE Personal EV Transport. The vehicle, built especially by Harvey Coachworks of Knoxville, MD., will be offered for auction on EBay.com under “AMA Celebrity BugE” from Dec 10th to Dec 20th to benefit Autism Speaks,